Page last updated: 2024-08-21

pyrazines and Lymph Node Metastasis

pyrazines has been researched along with Lymph Node Metastasis in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (25.00)	29.6817
2010's	3 (75.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Horn, L; Jie, F; Kelly, RJ; Krivoshik, A; Shepherd, FA	1
Christensen, JG; Ishiguro-Oonuma, T; McDonald, DM; Schriver, BJ; Sennino, B	1
Besse, B; Ducourtieux, M; Khayat, D; Lafontaine, C; Lumbroso, J; Mathiot, C; Pignon, JP; Planchard, D; Soria, JC; Taillade, L; Veillard, AS	1
Ling, CQ; Wang, X	1

Reviews

1 review(s) available for pyrazines and Lymph Node Metastasis

Article	Year
[Progress of the study on effective integredients from Chinese herbal medicine in anti-tumor metastasis]. Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine, 2004, Volume: 24, Issue:2 Topics: Alkaloids; Angiogenesis Inhibitors; Antineoplastic Agents, Phytogenic; Drugs, Chinese Herbal; Ginsenosides; Humans; Lymphatic Metastasis; Matrines; Pyrazines; Quinolizines	2004

Article

Year

[Progress of the study on effective integredients from Chinese herbal medicine in anti-tumor metastasis].

Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine, 2004, Volume: 24, Issue:2

Topics: Alkaloids; Angiogenesis Inhibitors; Antineoplastic Agents, Phytogenic; Drugs, Chinese Herbal; Ginsenosides; Humans; Lymphatic Metastasis; Matrines; Pyrazines; Quinolizines

2004

Trials

2 trial(s) available for pyrazines and Lymph Node Metastasis

Article	Year
A phase III, randomized, open-label study of ASP8273 versus erlotinib or gefitinib in patients with advanced stage IIIB/IV non-small-cell lung cancer. Annals of oncology : official journal of the European Society for Medical Oncology, 2019, 07-01, Volume: 30, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; ErbB Receptors; Erlotinib Hydrochloride; Female; Follow-Up Studies; Gefitinib; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Mutation; Neoplasm Recurrence, Local; Neoplasm Staging; Piperazines; Piperidines; Protein Kinase Inhibitors; Pyrazines; Pyrrolidines; Survival Rate	2019
Phase 2 study of frontline bortezomib in patients with advanced non-small cell lung cancer. Lung cancer (Amsterdam, Netherlands), 2012, Volume: 76, Issue:1 Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Boronic Acids; Bortezomib; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Follow-Up Studies; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplastic Cells, Circulating; Prognosis; Pyrazines; Survival Rate	2012

Article

Year

A phase III, randomized, open-label study of ASP8273 versus erlotinib or gefitinib in patients with advanced stage IIIB/IV non-small-cell lung cancer.

Annals of oncology : official journal of the European Society for Medical Oncology, 2019, 07-01, Volume: 30, Issue:7

Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; ErbB Receptors; Erlotinib Hydrochloride; Female; Follow-Up Studies; Gefitinib; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Mutation; Neoplasm Recurrence, Local; Neoplasm Staging; Piperazines; Piperidines; Protein Kinase Inhibitors; Pyrazines; Pyrrolidines; Survival Rate

2019

Phase 2 study of frontline bortezomib in patients with advanced non-small cell lung cancer.

Lung cancer (Amsterdam, Netherlands), 2012, Volume: 76, Issue:1

Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Boronic Acids; Bortezomib; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Follow-Up Studies; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplastic Cells, Circulating; Prognosis; Pyrazines; Survival Rate

2012

Other Studies

1 other study(ies) available for pyrazines and Lymph Node Metastasis

Article	Year
Inhibition of c-Met reduces lymphatic metastasis in RIP-Tag2 transgenic mice. Cancer research, 2013, Jun-15, Volume: 73, Issue:12 Topics: Animals; Antibodies; Antineoplastic Agents; Gene Expression Regulation, Neoplastic; Immunohistochemistry; Indoles; Lymphatic Metastasis; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microscopy, Confocal; Pancreatic Neoplasms; Phosphorylation; Proto-Oncogene Proteins c-met; Pyrazines; Pyrroles; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Sunitinib; Triazoles; Vascular Endothelial Growth Factor C	2013

Article

Year

Inhibition of c-Met reduces lymphatic metastasis in RIP-Tag2 transgenic mice.

Cancer research, 2013, Jun-15, Volume: 73, Issue:12

Topics: Animals; Antibodies; Antineoplastic Agents; Gene Expression Regulation, Neoplastic; Immunohistochemistry; Indoles; Lymphatic Metastasis; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microscopy, Confocal; Pancreatic Neoplasms; Phosphorylation; Proto-Oncogene Proteins c-met; Pyrazines; Pyrroles; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Sunitinib; Triazoles; Vascular Endothelial Growth Factor C

2013